Skip to content
VuFind
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
Advanced
  • Retraction notice to “Use of i...
  • Cite this
  • Text this
  • Email this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Permanent link
Retraction notice to “Use of ivermectin in the treatment of Covid-19: A pilot trial” [Toxicol. Rep. 8 (2021) 505–510]

Retraction notice to “Use of ivermectin in the treatment of Covid-19: A pilot trial” [Toxicol. Rep. 8 (2021) 505–510]

Bibliographic Details
Main Authors: Henrique Pott-Junior, Mônica Maria Bastos Paoliello, Alice de Queiroz Constantino Miguel, Anderson Ferreira da Cunha, Caio Cesar de Melo Freire, Fábio Fernandes Neves, Lucimar Retto da Silva de Avó, Meliza Goi Roscani, Sigrid De Sousa dos Santos, Silvana Gama Florêncio Chach´
Format: Article
Language:English
Published: Elsevier 2022-01-01
Series:Toxicology Reports
Online Access:http://www.sciencedirect.com/science/article/pii/S2214750022000920
  • Holdings
  • Description
  • Similar Items
  • Staff View

Internet

http://www.sciencedirect.com/science/article/pii/S2214750022000920

Similar Items

  • Retraction notice to “Why are we vaccinating children against COVID-19?” [Toxicol. Rep. 8 (2021) 1665–1684]
    by: Ronald N. Kostoff, et al.
    Published: (2022-01-01)
  • Insuficiência Cardíaca Avançada e o Surgimento de Novos Marcadores de Prognóstico: Onde Estamos?
    by: Meliza Goi Roscani
    Published: (2024-09-01)
  • Corrigendum to “Analysis of waterpipe aerosol constituents in accordance with the ISO standard 22486” [Toxicol. Rep. 7 (2020) 1344–1349]
    by: Guy Jaccard, et al.
    Published: (2024-12-01)
  • Corrigendum to “Toxicopathological, proinflammatory and stress response evaluation of Terminalia catappa extract in male Wistar rats” [Toxicol. Rep. 8 (2021) 1769–1776]
    by: Franklyn Nonso Iheagwam, et al.
    Published: (2024-06-01)
  • Corrigendum to “Cadmium sulfide-induced toxicity in the cortex and cerebellum: In vitro and in vivo studies” [Toxicol. Rep. 7 (2020) 637–648]
    by: Atefeh Varmazyari, et al.
    Published: (2024-12-01)

Search Options

  • Search History
  • Advanced Search

Find More

  • Browse the Catalog
  • Browse Alphabetically
  • Explore Channels
  • Course Reserves
  • New Items

Need Help?

  • Search Tips
  • Ask a Librarian
  • FAQs